botox

    Botox vs. Dysport vs. Xeomin vs. Jeuveau: What's the Difference?

    Last reviewed: May 2026 · Haute MD Editorial Team

    Botox (onabotulinumtoxinA), Dysport (abobotulinumtoxinA), Xeomin (incobotulinumtoxinA), and Jeuveau (prabotulinumtoxinA) are all FDA-approved botulinum toxin type A products with the same mechanism of action — blocking acetylcholine release at the neuromuscular junction. They are not interchangeable unit-for-unit: Dysport units are approximately 2.5-3x lower potency per unit than Botox, requiring more units for equivalent effect. An experienced injector who uses multiple products adjusts dosing appropriately and achieves comparable results across all four.

    The practical differences that actually matter

    Onset — Dysport typically shows effect 1-2 days faster than Botox (2-3 days vs. 3-5 days). This matters for patients with events in close timelines. Spread — Dysport tends to diffuse over a slightly wider area from the injection point, which can be advantageous for large treatment areas (forehead) and disadvantageous for precise small-area injection (lip lines, individual crow's feet). Xeomin — lacks the complexing proteins present in Botox and Dysport, theoretically reducing antibody formation risk with very frequent treatments. Duration — all four products last approximately 3-4 months in most patients, with no clinically meaningful differences in well-controlled studies. Price — varies by product and provider; Jeuveau is typically priced lower, sometimes marketed as the "newtox."

    Why the injector matters more than the product

    For the vast majority of patients and most treatment areas, the product matters far less than the injector's skill, dosing philosophy, and anatomical knowledge. A skilled injector using Dysport produces results indistinguishable from an equally skilled injector using Botox. Inexperienced injectors produce inferior results regardless of which premium product they use. When evaluating a provider, spend far more time reviewing their portfolio and assessing their aesthetic philosophy than asking which brand they use.

    Brand loyalty vs. clinical judgment

    Patients who have had optimal results with a specific product at a specific dose have reasonable grounds to request that product — muscle response patterns are somewhat individual, and a protocol that works perfectly for a patient is worth preserving. However, concerns about switching products are often more marketing-driven than clinically significant. If your provider switches products and adjusts dosing appropriately, results should be equivalent. The important question is not "which brand" but "how many units" and "exactly where are you placing them."

    Frequently Asked Questions

    Is Dysport better than Botox?

    Neither is categorically better — both produce equivalent cosmetic results in experienced hands. Dysport may onset slightly faster and spread slightly more. Some injectors prefer Dysport for large areas (forehead) and Botox for precise areas (around the eyes). The injector's experience and technique matter far more than the product selection.

    Is Xeomin safer than Botox?

    Both are safe in experienced hands. Xeomin lacks the complexing proteins present in Botox, which theoretically could reduce the already very low risk of antibody formation with very frequent treatments. For the vast majority of cosmetic patients treated 3-4 times per year, this distinction is clinically insignificant.

    Why does neurotoxin pricing vary so much?

    Pricing varies based on unit count placed, product used, provider overhead, and geography. Low per-unit pricing is sometimes offset by fewer units placed, producing shorter-lasting or less effective results. A full forehead plus glabellar plus crow's feet treatment uses 30-60 units depending on anatomy — ask providers explicitly how many units are included in their quoted price.

    What is Daxxify and how does it compare?

    Daxxify (daxibotulinumtoxinA) is an FDA-approved neurotoxin that uses a peptide stabilizer instead of albumin, producing results lasting 6-9 months in clinical trials — significantly longer than the 3-4 month duration of other neurotoxins. It is newer to the market and may not be available at all practices. For patients who want fewer annual treatments, it represents a meaningful option worth discussing with an experienced injector.

    Get Help Now

    Speak with a Haute MD Dermatology physician

    Are you a Dermatology physician?

    Join Haute MD Network and have your profile featured alongside these answers.

    Apply for the Network

    Related Guides

    Are you a botox physician?

    Join Haute MD Network and have your profile featured alongside these answers — published on HauteLiving.com, a verified Google News publisher since 2005.

    Apply for the Network